Clinical trial
Lymphocyte Depletion and Stem Cell Transplantation to Treat Severe Systemic…
NCT00076752 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00076752 |
|---|---|
| Title | Lymphocyte Depletion and Stem Cell Transplantation to Treat Severe Systemic Lupus Erythematosus |
| Official title | A Pilot Study of Intensified Lymphodepletion Followed by Autologous Hematopoietic Stem Cell Transplantation in Patients With Severe Systemic Lupus Erythematosus |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lupus Erythematosus, Systemic |
| Intervention type | Biological, Drug, Other, Procedure |
| Interventions | fludarabine phosphate, cyclophosphamide, Rituxan (rituximab), filgrastim, methylprednisolone, immunologic technique, laboratory biomarker analysis, autologous hematopoietic stem cell transplantation, Diphenhydramine, Mesna |
| Enrollment | 9 |
| Start date | Jan 30, 2004 |
| Primary completion | Oct 15, 2013 |
| Completion | Oct 15, 2013 |
| First posted | Feb 3, 2004 |
| Last update posted | Jan 5, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: